Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • rheumatoid arthritis

    - PMLiVE

    Roche’s Columvi improves survival in large B-cell lymphoma

    Approximately 160,000 people are diagnosed with this aggressive form of cancer each year

    - PMLiVE

    Roche receives FDA clearance for whooping cough test

    There are around 24.1 million cases of whooping cough annually, with around 170,000 deaths

    - PMLiVE

    Genentech announces positive clinical results for BTK inhibitor MS treatment

    Multiple sclerosis affects more than 2.9 million people globally

    - PMLiVE

    Roche’s small cell lung cancer therapy approved by FDA

    This is the first and only approved combination therapy for extensive-stage small cell lung cancer

    - PMLiVE

    Roche’s Lunsumio receives positive CHMP opinion for follicular lymphoma

    The recommendation for the subcutaneous formulation follows encouraging trial data

    - PMLiVE

    Roche to acquire 89bio in a deal worth up to US$3.5bn

    With the agreement, Roche will gain a treatment for moderate to severe MASH

    - PMLiVE

    Genentech starts construction on manufacturing facility in North Carolina, US

    The $700m project is part of Roche’s $50bn investment in the US

    - PMLiVE

    FDA approves Celltrion’s Actemra biosimilar Avtozma for cytokine release syndrome

    Avtozma IV now fully aligns with all indications covered by Actemra IV in the US

    - PMLiVE

    Roche’s Evrysdi tablets approved by MHRA to treat spinal muscular atrophy

    It is hoped the new formulation will offer patients greater freedom and flexibility compared to the liquid version

    - PMLiVE

    Roche shares promising data from Alzheimer’s disease development portfolio

    The company is planning to initiate phase 3 studies of trontinemab in early AD this year

    - PMLiVE

    Roche’s Itovebi granted EC approval to treat advanced breast cancer patients

    Hormone receptor-positive breast cancer accounts for around 70% of all breast cancer cases

    - PMLiVE

    Roche to advance Parkinson’s disease candidate into phase 3 development

    More than ten million people worldwide are living with the neurodegenerative disorder

    Subscribe to our email news alerts

    Latest content

    Latest intelligence

    Quick links